Next-Generation Sequencing (NGS) Services Market
Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Global Forecast to 2022
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The next-generation sequencing services market is projected to reach USD 8.77 billion by 2030 from USD 3.80 billion in 2025, at a CAGR of 18.2% from 2025 to 2030. The global next-generation sequencing services market is growing as sequencing is used more widely in oncology, rare disease diagnostics, infectious disease monitoring, and broader precision medicine initiatives, with healthcare providers and biopharmaceutical companies increasingly outsourcing complex genomic workflows to specialized service partners.
KEY TAKEAWAYS
-
By RegionThe North American next-generation sequencing services market accounted for a 40.8% revenue share in 2024.
-
By OfferingsBy offering, the products segment dominated the next-generation sequencing services market in 2024.
-
By Service typeBy type, the services segment is expected to register the highest CAGR of 18.0%.
-
By End userIn the next-generation sequencing services end user market, the academic & research institutes segment is projected to grow at the fastest rate from 2025 to 2030.
-
By ApplicationBy application, the diagnostics segment is projected to grow at the fastest rate from 2025 to 2030.
-
Competitive LandscapeIllumina, Inc., Thermo Fisher Scientific, and Eurofins Scientific were identified as some of the star players in the North American next-generation sequencing services market, given their strong market share and product footprint.
-
Competitive LandscapeNovogene, Co. Ltd., MedGenome, and Singular Genomics, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders
The?????? global next-generation sequencing services market continues to grow significantly as a larger number of organizations decide to use sequencing services outside their own facilities to obtain quality genomic data. There is an increasing need for services that facilitate the earlier and more accurate detection of diseases, the selection of appropriate therapies, and the application of translational research, both in clinical and research domains. The speed of the cancer-related application (tumor profiling, MRD, liquid biopsy) usage, as well as rare and inherited diseases testing, reproductive health screening, and infectious disease surveillance, is going ??????up.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The impact on stakeholders of the next-generation sequencing services market is evolving in line with shifting healthcare priorities, rapid advancements in sequencing technologies and analytics, and increasing demand for personalized, data-rich care worldwide. Hospitals and clinical labs, as well as academic and public research centers, and pharmaceutical and biotechnology companies, are the primary customers for outsourced NGS services, which are deployed for oncology, rare disease testing, reproductive health, infectious disease applications, and drug discovery.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Population genomics and pathogen surveillance programs creating steady service volumes
-
Falling sequencing cost and easy access to scalable capacity
Level
-
Uneven reimbursement and limited coverage for clinical sequencing
Level
-
Multi-omics service bundles for drug discovery and translational research
-
Sample-to-report' diagnostic services with interpretation and reanalysis
Level
-
hortage of specialized talent in bioinformatics and clinical interpretation
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Population genomics and pathogen surveillance programs creating steady service volumes
Many countries are funding large genomics and surveillance efforts. These programs require consistent throughput and repeated testing over extended periods. Service providers benefit because they can centralize workflows and scale quickly. This drives recurring demand for sequencing, plus analysis and reporting.
Restraint: Uneven reimbursement and limited coverage for clinical sequencing
Payment pathways still vary widely by country and payer. Hospitals may hesitate to send routine cases when reimbursement is unclear, which slows adoption in diagnostics, even when clinical value is recognized. Service volumes then grow unevenly across regions and indications.
Opportunity: Growth of multi-omics, data analytics, and biopharma collaborations
Clients are increasingly requiring the integration of genomics with transcriptomics and other omics layers. This improves target identification, biomarker work, and patient stratification. Service providers can solve bigger programs by offering one integrated workflow. Demand rises further when analysis, interpretation, and sequencing are included.
Challenge: Shortage of specialized talent in bioinformatics and clinical interpretation
Scaling services needs trained analysts, in addition to sequencing machines. Many regions face gaps in genomics data science and reporting expertise; this can hit turnaround time and create bottlenecks as volumes rise. Providers must invest in training, automation, and standardized pipelines to keep pace.
NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Scientists studying Usutu virus sent viral nucleic acid to Eurofins Genomics for a dedicated RNA-virus sequencing service (INVIEW virus sequencing) on an Illumina NovaSeq 6000 to generate whole-genome data for analysis and comparison with other methods | Quick access to high-quality viral genomes | High-throughput sequencing without adding lab capacity | Supports surveillance and phylogenetics | Clean data for downstream bioinformatics |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The global next-generation sequencing services market environment comprises sequencing service providers, specialty clinical labs, and research-focused genomics partners. These entities perform high-throughput workflows for whole-genome, whole-exome, targeted panels, RNA sequencing, metagenomics, and single-cell projects. A large number of them also offer the services of sample handling, library preparation, QC, bioinformatics, and interpretation, so that customers obtain the most processed results and not just raw data. On the demand side, biopharma companies, CROs, hospitals, reference labs, academic centers, and public health agencies are the primary users. They use service providers as a means to scale their programs in oncology, rare disease testing, reproductive health, infectious disease surveillance, and drug ??????discovery.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
NGS Services Market, By Service type
As of 2024, sequencing services accounted for the largest share of the global next-generation sequencing services market and are expected to remain the leading service type over the next several years. This is driven by steady demand from clinical labs, hospitals, academic centers, and biopharmaceutical companies for scalable access to whole-genome sequencing, whole-exome sequencing, targeted panels, RNA sequencing, and metagenomics without the need to expand in-house capacity.
NGS Services Market, By Workflow
As of 2024, the sequencing step accounted for the largest share of the global next-generation sequencing services market by workflow and is expected to remain the dominant step over the next several years. This is because sequencing is the core value-creating activity that determines data yield, accuracy, turnaround time, and cost per sample. Service providers generate the majority of their workflow revenue by running high-throughput sequencing across WGS, WES, targeted panels, RNA-seq, and metagenomics for clinical and research customers.
NGS Services Market, By Application
As of 2024, the diagnostics sector was the major contributor to the global next-generation sequencing services market in terms of application and is anticipated to maintain its dominance for the following years. A key factor supporting this trend is the fact that clinical users are turning to external sequencing services more and more in order to obtain ready-to-report results without the need to set up large in-house sequencing and bioinformatics teams. The highest demand for diagnostic services is associated with oncology profiling (support for tissue and liquid biopsies), genetic and rare disease testing, reproductive health screening, as well as infectious disease identification and surveillance.
NGS Services Market, By End user
As?????? of 2024, academic & research institutes were the major contributors to the global next-generation sequencing services market by end user and are projected to remain the leading segment during the forecast period. These institutions, universities, and research centers are involved in numerous projects, including whole-genome, whole-exome, RNA-seq, metagenomics, and single-cell studies. To get high-throughput capacity and save on the costs of instruments and staff in their labs, they frequently outsource ??????sequencing.
REGION
Asia Pacific to be the fastest-growing region in the global NGS services market during the forecast period
The next-generation sequencing services market is expected to grow significantly over the forecast period, driven by the expansion of genomics and precision medicine programs across countries such as China, India, Japan, and South Korea. Growth is further propelled by rising biopharmaceutical R&D and clinical trials that rely on NGS-based biomarker discovery, together with a rapidly expanding molecular diagnostics and oncology testing ecosystem and increasing investments in automation, AI-enabled bioinformatics, and cloud-based data platforms to support high-throughput and decentralized sequencing workflows.
NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET: COMPANY EVALUATION MATRIX
In the global next-generation sequencing services matrix, Illumina (Star) is combining a technological ecosystem to capture a large share of the outsourced sequencing capacity globally, which supports its leading position. By using Illumina platforms, service providers and large reference labs carry out high-throughput whole-genome, whole-exome, targeted panel, and RNA sequencing. WuXi Biologics (Emerging Leader) is becoming more prominent on the services side as biopharma customers increasingly seek partners who can provide them with end-to-end development support, along with strong analytical capabilities. Although WuXi Biologics is not a purely sequencing lab, its expanding involvement in biologics development and manufacturing is attracting more demand for sequencing-enabled workflows linked to cell line and clone characterization, genetic stability, and translational support.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Illumina, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- Eurofins Scientific (Luxembourg)
- Wuxi Biologics (China)
- Qiagen (Netherlands)
- Revvity (US)
- BGI Group (China)
- Macrogen, Inc. (South Korea)
- Azenta US (US)
- Novogene Co. Ltd (China)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 3.40 Billion |
| Market Forecast in 2030 (Value) | USD 8.78 Billion |
| Growth Rate | CAGR of 18.2% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
WHAT IS IN IT FOR YOU: NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Global NGS service provider / sequencing lab network | Competitive benchmarking of global NGS service providers by service menu (WGS/WES/panels/RNA-seq/metagenomics/single-cell), pricing bands, and turnaround times |
|
| Bioinformatics / software platform company |
|
|
RECENT DEVELOPMENTS
- April 2024 : Eurofins Scientific (Luxembourg) entered into a collaboration agreement with Oncocyte Corporation (US) to develop and commercialize transplant monitoring products.
- October 2023 : Revvity (US) collaborated with Element Biosciences (US) to upgrade the genomic analysis of samples.
- July 2022 : BGI Group (China) announced the launch of HotMPS sequencing chemistry and services in the UK
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Research Approach
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Data
2.2.2.1 Breakdown of Primaries
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 27)
4 Premium Insights (Page No. - 31)
4.1 Next-Generation Sequencing (NGS) Services Market Overview
4.2 Global NGS Services Market, By Type, 2015 vs 2017 vs 2022 (USD Million)
4.3 Geographic Analysis: NGS Services Market, By Technology (2017)
4.4 NGS Services Market, By Application
4.5 Global NGS Services Market, By End User, 2017 vs 2022
4.6 Geographical Snapshot of the NGS Services Market
5 Market Overview (Page No. - 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Declining Price of Sequencing
5.2.1.2 High Cost of Sequencing Infrastructure
5.2.1.3 Need for Skilled Professionals for Efficient NGS Sample Preparation and Analysis
5.2.1.4 Sequencing Services, the Preferred Option for NGS Applications With Low Throughput Requirements
5.2.1.5 Technological Advancements in the Field of Sequencing
5.2.2 Restraints
5.2.2.1 Installation of In-House Sequencing Facilities in Hospitals and Universities
5.2.3 Opportunities
5.2.3.1 Analysis of Complex Sequencing Data
5.2.3.2 Increasing Applications in Cancer and Agrigenomics Research
5.2.4 Challenges
5.2.4.1 Accuracy & Standardization Concerns in Diagnostic Testing
5.2.4.2 Ethical Issues Related to NIPT
6 Global Next-Generation Sequencing Services Market, By Technology (Page No. - 42)
6.1 Introduction
6.2 Sequencing By Synthesis
6.3 Ion Semiconductor Sequencing
6.4 Single-Molecule Real-Time Sequencing
6.5 Nanopore Sequencing
7 Global NGS Services Market, By Service Type (Page No. - 49)
7.1 Introduction
7.2 Targeted Resequencing & Custom Gene Panels
7.3 RNA-Seq
7.4 De Novo Sequencing
7.5 Exome Sequencing
7.6 Chip-Seq
7.7 Whole-Genome Sequencing
7.8 Methyl-Seq
7.9 Other Services
8 Next-Generation Sequencing Services Market, By Application (Page No. - 59)
8.1 Introduction
8.2 Diagnostics
8.2.1 Oncology
8.2.2 Infectious Diseases
8.2.3 Rare Genetic Disorders
8.2.4 Reproductive Health
8.2.5 Other Diagnostic Applications
8.3 Drug Discovery
8.4 Biomarker Discovery
8.5 Agriculture & Animal Research
8.6 Other Applications
9 Next-Generation Sequencing Services Market, By End User (Page No. - 72)
9.1 Introduction
9.1.1 Academic & Government Institutes and Research Centers
9.1.2 Hospitals & Clinics
9.1.3 Pharmaceutical & Biotechnology Companies
9.1.4 Other End Users
10 Global Next-Generation Sequencing Services Market, By Region (Page No. - 78)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World
11 Competitive Landscape (Page No. - 105)
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Leadership Benchmarking
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Strength of Product Portfolio (For 25 Players)
11.5 Business Strategy Excellence (For 25 Players)
*Top 25 Companies Analyzed for This Study are - Illumina, Inc., BGI, Eurofins Scientific SE, Perkinelmer, Inc., Qiagen N.V., Gatc Biotech AG, Macrogen Inc., DNA Link, Inc, Genotypic Technology Pvt Ltd, Wuxi Apptec, Genewiz, Inc., Takara Bio Inc., Scigenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Genomics Limited, Oxford Gene Technology, Sysmex Corporation, Genomics Biosci & Tech. Co., Ltd., Zymo Research Corp, Source Bioscience, Integragen Sa, Centogene AG, Otogenetics Corporation, Novogene Corporation, Personalis, Inc.
12 Company Profiles (Page No. - 110)
12.1 Introduction
(Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
12.2 BGI
12.3 Illumina, Inc.
12.4 Perkinelmer, Inc.
12.5 Eurofins Scientific SE
12.6 Gatc Biotech AG
12.7 Macrogen, Inc.
12.8 Qiagen N.V.
12.9 Genotypic Technology Pvt. Ltd.
12.10 Genewiz, Inc.
12.11 DNA Link, Inc.
12.12 Takara Bio Inc. (Part of Takara Holding Company Inc.)
12.13 Scigenom Labs Pvt. Ltd
12.14 Novogene Corporation
12.15 Personalis, Inc.
12.16 LGC Limited (A Part of KKR & Co. L.P.)
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 147)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details
List of Tables (56 Tables)
Table 1 NGS Services Market, By Region, 2015–2022 (USD Million)
Table 2 NGS Services Market for Sequencing By Synthesis, By Region, 2015–2022 (USD Million)
Table 3 NGS Services Market for Ion Semiconductor Sequencing, By Region, 2015–2022 (USD Million)
Table 4 NGS Services Market for Single-Molecule Real-Time Sequencing, By Region, 2015–2022 (USD Million)
Table 5 NGS Services Market for Nanopore Sequencing, By Region, 2015–2022 (USD Million)
Table 6 NGS Services Market, By Type, 2015–2022 (USD Million)
Table 7 Targeted Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 8 RNA-Seq Services Market, By Region, 2015–2022 (USD Million)
Table 9 De Novo Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 10 Exome Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 11 Chip-Seq Services Market, By Region, 2015–2022 (USD Million)
Table 12 Whole-Genome Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 13 Methyl-Seq Services Market, By Region, 2015–2022 (USD Million)
Table 14 Other NGS Services Market, By Region, 2015–2022 (USD Million)
Table 15 Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 16 NGS Diagnostic Services Market, By Application, 2015–2022 (USD Million)
Table 17 Next-Generation Sequencing Services Market for Diagnostic Applications, By Region, 2015–2022 (USD Million)
Table 18 Next-Generation Sequencing Services Market for Drug Discovery, By Region, 2015–2022 (USD Million)
Table 19 Next-Generation Sequencing Services Market for Biomarker Discovery, By Region, 2015–2022 (USD Million)
Table 20 Next-Generation Sequencing Services Market for Agriculture and Animal Research, By Region, 2015–2022 (USD Million)
Table 21 Next-Generation Sequencing Services Market for Other Applications, By Region, 2015–2022 (USD Million)
Table 22 Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)
Table 23 Next-Generation Sequencing Services Market for Academic & Government Institutes and Research Centers, By Region, 2015–2022 (USD Million)
Table 24 Next-Generation Sequencing Services Market for Hospitals & Clinics, By Region, 2015–2022 (USD Million)
Table 25 Next-Generation Sequencing Services Market for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 26 Next-Generation Sequencing Services Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 27 Next-Generation Sequencing Services Market, By Region, 2015–2022 (USD Million)
Table 28 North America: Next-Generation Sequencing Services Market, By Country, 2015–2022 (USD Million)
Table 29 North America: Next-Generation Sequencing Services Market, By Type, 2015–2022 (USD Million)
Table 30 North America: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 31 North America: Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 32 North America: Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)
Table 33 U.S.: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 34 Canada: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 35 Europe: Next-Generation Sequencing Services Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Next-Generation Sequencing Services Market, By Type, 2015–2022 (USD Million)
Table 37 Europe: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 38 Europe: Next-Generation Sequencing Services Market, By Application, 2015–2022 (USD Million)
Table 39 Europe: Next-Generation Sequencing Services Market, By End User, 2015–2022 (USD Million)
Table 40 Germany: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 41 U.K.: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 42 France: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 43 RoE: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 44 Asia-Pacific: Next-Generation Sequencing Services Market, By Country, 2015–2022 (USD Million)
Table 45 Asia-Pacific: Market, By Type, 2015–2022 (USD Million)
Table 46 Asia-Pacific: Market, By Technology, 2015–2022 (USD Million)
Table 47 Asia-Pacific: Market, By Application, 2015–2022 (USD Million)
Table 48 Asia-Pacific: Market, By End User, 2015–2022 (USD Million)
Table 49 China: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 50 Japan: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 51 India: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 52 RoAPAC: Next-Generation Sequencing Services Market, By Technology, 2015–2022 (USD Million)
Table 53 RoW: Next-Generation Sequencing Services Market, By Type, 2015–2022 (USD Million)
Table 54 RoW: Market, By Technology, 2015–2022 (USD Million)
Table 55 RoW: Market, By Application, 2015–2022 (USD Million)
Table 56 RoW: Market, By End User, 2015–2022 (USD Million)
List of Figures (38 Figures)
Figure 1 Global NGS Services Market: Research Approach
Figure 2 Research Design
Figure 3 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 4 NGS Services Market: Bottom-Up Approach
Figure 5 NGS Services Market: Top-Down Approach
Figure 6 NGS Services Market: Data Triangulation
Figure 7 Next-Generation Sequencing Services Market, By Type, 2017 vs 2022
Figure 8 Market, By Technology, 2017 vs 2022 (USD Million)
Figure 9 Market, By Application, 2017 vs 2022 (USD Million)
Figure 10 Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Geographical Snapshot of the Next-Generation Sequencing Services Market
Figure 12 Increasing Applications of NGS in Cancer and Agrigenomics Research to Offer Significant Growth Opportunities During the Forecast Period
Figure 13 North America to Dominate the NGS Services Market in 2017
Figure 14 Agriculture & Animal Research Segment to Register the Highest Growth Rate in the NGS Services Market Between 2017 & 2022
Figure 15 Academic & Government Institutes and Research Centers Segment Will Continue to Dominate the Global NGS Services Market in 2022
Figure 16 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 17 Next-Generation Sequencing Services Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Human Whole-Genome Sequencing Cost Estimated By the National Human Genome Research Institute
Figure 19 Nanopore Sequencing to Register the Highest Growth During the Forecast Period (2017 to 2022)
Figure 20 NGS Services Market, By Technology, 2015–2022 (USD Million)
Figure 21 Targeted Resequencing/Custom Gene Panels Segment Will Continue to Dominate the Global Next-Generation Sequencing Services Market in 2022
Figure 22 Diagnostics Segment Will Continue to Dominate the Global Next-Generation Sequencing Services Market in 2022
Figure 23 Growth in Number of Genetic Tests (2012–2016)
Figure 24 Increasing Publications Related to Biomarker Discovery Based on NGS During 2011-2016
Figure 25 Academic & Government Institutes and Research Centers to Register the Highest CAGR in the Forecast Period
Figure 26 Next-Generation Sequencing Services Market, By Region
Figure 27 North America: Next-Generation Sequencing Services Market Snapshot
Figure 28 Europe: Next-Generation Sequencing Services Market Snapshot
Figure 29 Asia-Pacific: Next-Generation Sequencing Services Market Snapshot
Figure 30 RoW: Next-Generation Sequencing Services Market Snapshot
Figure 31 BGI, Eurofins Scientific Se, and Macrogen Were the Leading Providers for NGS Services Worldwide in 2016
Figure 32 NGS Services Market (Global) Competitive Leadership Mapping, 2017
Figure 33 Illumina, Inc.: Company Snapshot (2016)
Figure 34 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 35 Eurofins Scientific Se: Company Snapshot (2016)
Figure 36 Macrogen, Inc.: Company Snapshot (2015)
Figure 37 Qiagen N.V.: Company Snapshot (2016)
Figure 38 Takara Bio Inc.: Company Snapshot (2016)
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Next-Generation Sequencing (NGS) Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Next-Generation Sequencing (NGS) Services Market